MedTrace Logo

Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers

NCT01104714 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2015-03-26

No results posted yet for this study

Summary

The purpose of this study is to determine if there is a correlation between tumor response after 3 doses of chemotherapy by induction using Docetaxel, Cisplatine and 5-Fluorouracile for advanced stage epidermoid carcinomas of the upper aero digestive tract and the presence of one or a combination of 3 genetic polymorphisms and/or 5 intra-tumoral transcriptional modifications.

Conditions

  • Carcinoma, Squamous Cell
  • Mouth Neoplasms
  • Oropharyngeal Neoplasms
  • Laryngeal Neoplasms
  • Hypopharyngeal Neoplasms

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Benjamin Lallemant, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01104714 on ClinicalTrials.gov